Cochrane · systematic review · CD004135
Transurethral microwave thermotherapy for the treatment of lower urinary tract symptoms in men with benign prostatic hyperplasia
Franco, JVA, Garegnani, L, Escobar Liquitay, CM, et al. · Cochrane Database of Systematic Reviews · 2021 · Cochrane Library
SoF tableOnly the outcomes this review put in its Summary of Findings table are listed (the Cochrane Handbook caps them at about seven per comparison). Its other analyses are not shown here.
Questions
12
current version
GRADE rated
12
No studies
0
Included studies
NR
No studies 0 · 0%Ungraded 0 · 0%Very low 3 · 25%Low 4 · 33.3%Moderate 5 · 41.7%High 0 · 0%
Ungraded means an effect was reported without a GRADE rating; it is not a gap. No studies means the review found nothing to answer the question. The six categories are a display order, not a score.
Questions and results
Current version onlyTransurethral microwave thermotherapy compared to transurethral resection of the prostate for the treatment of lower urinary tract symptoms in men with benign prostatic hyperplasia
Population: men with lower urinary tract symptoms due to benign prostatic hyperplasia
| Outcome | Effect | Evidence | Status / GRADE |
|---|---|---|---|
Urologic symptom scores Transurethral microwave thermotherapy vs transurethral resection of the prostate | no estimate extracted | 4 studies · 306 participants | Moderate Downgraded: risk of bias |
Quality of life Transurethral microwave thermotherapy vs transurethral resection of the prostate | no estimate extracted | 1 study · 136 participants | Moderate Downgraded: risk of bias |
Major adverse events Transurethral microwave thermotherapy vs transurethral resection of the prostate | RR 0.2 [0.09, 0.43] | 6 studies · 525 participants | Moderate Downgraded: risk of bias |
Retreatment Participants requiring additional procedures or surgery Transurethral microwave thermotherapy vs transurethral resection of the prostate | RR 7.07 [1.94, 25.82] | 5 studies · 463 participants | Moderate Downgraded: risk of bias, imprecision |
Erectile function (sexually‐active men only) Transurethral microwave thermotherapy vs transurethral resection of the prostate | RR 0.63 [0.24, 1.63] | 5 studies · 337 participants | Low Downgraded: risk of bias, imprecision |
Ejaculatory function (sexually‐active men only) Transurethral microwave thermotherapy vs transurethral resection of the prostate | RR 0.36 [0.24, 0.53] | 4 studies · 241 participants | Low Downgraded: risk of bias, imprecision |
Transurethral microwave thermotherapy compared to sham treatment for the treatment of lower urinary tract symptoms in men with benign prostatic hyperplasia
Population: men with lower urinary tract symptoms due to benign prostatic hyperplasia
| Outcome | Effect | Evidence | Status / GRADE |
|---|---|---|---|
Urologic symptom scores Transurethral microwave thermotherapy vs sham treatment | no estimate extracted | 4 studies · 483 participants | Moderate Downgraded: risk of bias |
Quality of life Transurethral microwave thermotherapy vs sham treatment | no estimate extracted | 2 studies · 347 participants | Low Downgraded: risk of bias, imprecision |
Major adverse events Transurethral microwave thermotherapy vs sham treatment | no estimate extracted | 8 studies · 924 participants | Very low Downgraded: risk of bias, imprecision |
Retreatment Participants requiring additional procedures or surgery Transurethral microwave thermotherapy vs sham treatment | RR 0.27 [0.08, 0.88] | 2 studies · 82 participants | Low Downgraded: risk of bias, imprecision |
Erectile function (sexually‐active men only) Transurethral microwave thermotherapy vs sham treatment | no estimate extracted | 3 studies · 375 participants | Very low Downgraded: risk of bias, imprecision |
Ejaculatory function (sexually‐active men only) Transurethral microwave thermotherapy vs sham treatment | no estimate extracted | 5 studies · 727 participants | Very low Downgraded: risk of bias, imprecision |
Comparison
Population: men with symptomatic benign prostatic hyperplasia
| Outcome | Effect | Evidence | Status / GRADE |
|---|---|---|---|
International Prostate Symptom Score (IPSS). | no estimate extracted | 306 participants | Moderate Downgraded: imprecision |
Madsen‐Iversen Symptom Score Range 0 to 27 points | no estimate extracted | 5 studies · 338 participants | Moderate Downgraded: imprecision |
Peak Flow Rate (Qmax): Measurement: mL per second | no estimate extracted | 2 studies · 108 participants | Moderate Downgraded: imprecision |